Skip to main content

Table 3 Performance of fluorescence imaging device to detect carcinoma in patients administered 5-ALA. Overall measures of diagnostic accuracy were calculated irrespective of the biopsy location (analysis combined biopsies collected inside and outside the tumor border). Areas of fluorescence images classified as negative or positive for PpIX red fluorescence (−Red FL/+Red FL) were biopsied and fluorescence imaging results were compared to gold-standard histological evaluation of biopsy H&E tissue sections performed by a blinded pathologist (S.J.D.)

From: Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial

  Low Dose (15 mg/kg) High Dose (30 mg/kg)
  -Cancer +Cancer -Cancer +Cancer
-Red FL 22 7 20 7
+Red FL 4 13 5 15
PPV
% (95%CI)
76.5%
(50.1 – 93.2)
75.0%
(50.9 – 91.3)
NPV
% (95%CI)
75.9%
(56.5 – 89.7)
74.1%
(53.7 – 88.9)
Sensitivity
% (95%CI)
65.0%
(40.8 – 84.6)
68.2%
(45.1 – 86.1)
Specificity
% (95%CI)
84.6%
(65.1 – 95.6)
80.0%
(59.3– 93.2)
DOR (95%CI) 13.6
(3.0 – 62.0)
8.6
(2.3 – 32.4)
  1. FL fluorescence, PPV positive predictive value, NPV negative predictive value, CI confidence interval, DOR diagnostic odds ratio, N/A not applicable